INTRODUCTION
In the search for antifertility agents attention has been focused on steroidal and non-steroidal compounds which either inhibit the development of the zygote (antizygotic agents) or prevent the implantation of the blastocyst (anti-implantation agents). Clomiphene, a non-steroidal compound structurally related to chlorotrianisene (tace), inhibits fertility in female rats if adminis¬ tered during the tubai passage of fertilized eggs (Segal & Nelson, 1961; Davidson, Wada & Segal, 1965 ; Barnes & Meyer, 1962) . Prasad, Kalra & Segal (1965) , Davidson, Wada & Segal (1965) and Schlough & Meyer (1965a) showed that clomiphene causes failure of implantation in rats during experi¬ mentally produced delayed implantation or during lactational delay. Since blastocysts were not recovered from the uterus following clomiphene adminis¬ tration, Prasad et al. suggested that clomiphene had a direct blastotoxic action. The failure of implantation after clomiphene administration may also be due to the expulsion of ova from the uterus (Chang, 1964) . The of the olive oil fed controls (Group 5) and in 75% of the clomiphene-fed rats (Groups 6 and 7) with an average of 3-6, 3-8 and 4 blastocysts/rat respectively. This is similar to the number of blastocysts recovered from the uteri of the nonligated group (Group 1). There is an apparent decrease in the percentage of rats with blastocysts in the olive oil-fed group (Group 5) but this is statistically not significant [P>0-05) from the percentages in the clomiphene-fed groups (Groups 6 and 7). Blastocysts recovered from the clomiphene-treated animals appeared morphologically normal. Table 2 shows the inhibition of oestrogen-induced implantation following clomiphene administration. Oestrogen treatment was initiated 6, 24 and 48 hr after the first feeding of clomiphene.
Administration of oestrogen to olive oil-fed controls ( A similar phenomenon may also account for the failure in our earlier work (Prasad et al., 1965) to recover blastocysts 5 days after clomiphene feeding and before the initiation of oestrogen treatment. These results are essentially in agreement with the observations of Greenwald (1957, 1959, 1961) , , Pincus & Banik (1963) , Pincus, Banik & Jacques (1964) , Davis (1963) and Chang (1964) , who showed that steroidal and non-steroidal com¬ pounds with oestrogenic activity cause the expulsion of eggs and blastocysts from the fallopian tube and uterus.
In order to understand the mode of action of clomiphene, it may be of interest to compare the antifertility effects of compounds derived from chlorotrianisene namely ethamoxytriphetol (MER-25), MRL-37 and clomiphene (MRL-41) with their known oestrogenic and anti-oestrogenic activities. MER-25 and MRL-37 are not oestrogenic at dose levels at which they show effective antifertility activity, an activity which may possibly be related to their anti-oestro¬ genic action (Emmens, 1965) . These compounds do not affect the viability of the blastocysts (Schlough & Meyer, 1965a) . On the other hand, clomiphene exhibits antifertility and oestrogenic activities at the same low dose level (Emmens, 1965) . The antifertility effects of clomiphene may possibly be due to the oestrogenicity of the compound (Kalra & Prasad, unpublished observations).
It is clear from our data shown in Table 1 (Noyes, Adams & Walton, 1959; Greenwald, 1961; Deanesly, 1963; Chang, 1964; Harper, 1964; and Lerner (1964) showed that clomiphene competes with oestrogen for binding sites in the uterus thus preventing the action of oestrogen injected subsequently. Shelesnyak (1957) has postulated that the pre-decidualization changes in the uterus are initiated by histamines which, in turn, are released by the action of oestrogens on the uterus; histamine-dependent decidual cell response may be prevented by antihistamines. Shelesnyak, Kraicer & Zeilmaker (1963) 
